Son zamanlarda BMC Cancer\u2019da yay\u0131mlanan \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 bir \u00e7al\u0131\u015fma, Chordin-like 1 (CHRDL1) proteininin bir\u00e7ok kanser t\u00fcr\u00fcndeki kritik rol\u00fcn\u00fc ortaya koydu. \u00d6zellikle akci\u011fer adenokarsinomunda (LUAD) \u00f6nemli etkileri g\u00f6sterilen CHRDL1, kemik morfogenetik proteinlerin (BMP) antagonisti olarak; t\u00fcm\u00f6r davran\u0131\u015f\u0131, ba\u011f\u0131\u015f\u0131kl\u0131k infiltrasyonu ve hastalar\u0131n prognozu \u00fczerinde \u00e7ok y\u00f6nl\u00fc etkiler g\u00f6steriyor. Pan-kanser analiziyle desteklenen ve deneysel do\u011frulamalarla g\u00fc\u00e7lendirilen bu \u00e7al\u0131\u015fma, CHRDL1\u2019in hem prognostik bir biyobelirte\u00e7 hem de tedavi hedefi olarak potansiyelini g\u00f6zler \u00f6n\u00fcne serdi.<\/p>\n
Ara\u015ft\u0131rmac\u0131lar, The Cancer Genome Atlas (TCGA) ve di\u011fer kamuya a\u00e7\u0131k veri tabanlar\u0131ndan faydalanarak, 33 farkl\u0131 kanser t\u00fcr\u00fcndeki CHRDL1 ekspresyonunu kapsaml\u0131 \u015fekilde inceledi. Analizler, CHRDL1 seviyelerinin t\u00fcm\u00f6r dokular\u0131nda sa\u011fl\u0131kl\u0131 dokulara k\u0131yasla belirgin \u015fekilde azald\u0131\u011f\u0131n\u0131 g\u00f6sterdi. Bu yayg\u0131n d\u00fc\u015f\u00fc\u015f, BMP sinyal yolunda d\u00fczenin bozuldu\u011funu ifade ederken, CHRDL1\u2019in bir t\u00fcm\u00f6r bask\u0131lay\u0131c\u0131 gen olarak i\u015flev g\u00f6rd\u00fc\u011f\u00fcn\u00fc ve bu proteinin yoklu\u011funun t\u00fcm\u00f6r ilerlemesini kolayla\u015ft\u0131rd\u0131\u011f\u0131n\u0131 d\u00fc\u015f\u00fcnd\u00fcr\u00fcyor.<\/p>\n
\u00c7al\u0131\u015fma, CHRDL1 ekspresyonunun \u00f6zellikle akci\u011fer adenokarsinomu, melanom ve mezotelyoma gibi belirli kanserlerde hastalar\u0131n sa\u011fkal\u0131m\u0131 ile do\u011frudan ba\u011flant\u0131l\u0131 oldu\u011funu ortaya koydu. D\u00fc\u015f\u00fck CHRDL1 d\u00fczeyine sahip hastalar daha k\u00f6t\u00fc klinik sonu\u00e7larla kar\u015f\u0131la\u015f\u0131rken, bu bulgu proteinin prognostik de\u011ferlendirilmelerde kullan\u0131lmas\u0131 i\u00e7in umut verdi. Bu \u015fekilde klinik kararlar\u0131n y\u00f6nlendirilmesi ve d\u00fc\u015f\u00fck CHRDL1 ekpresyonuna sahip hastalar\u0131n daha hedeflenmi\u015f tedavi stratejileriyle ele al\u0131nmas\u0131 \u00f6nem kazan\u0131yor.<\/p>\n
CHRDL1\u2019in ba\u011f\u0131\u015f\u0131kl\u0131k mikro\u00e7evresi ile kurdu\u011fu ili\u015fki dikkat \u00e7ekici bulundu. Y\u00fcksek CHRDL1 seviyeleri, CD4\u207a ve CD8\u207a T h\u00fccreleri, B h\u00fccreleri, n\u00f6trofiller, makrofajlar ve dendritik h\u00fccreler gibi ba\u011f\u0131\u015f\u0131kl\u0131k etkin h\u00fccrelerin t\u00fcm\u00f6r i\u00e7ine daha fazla yerle\u015fmesine pozitif olarak ba\u011fl\u0131 bulundu. Bu bulgu, CHRDL1\u2019in anti-t\u00fcm\u00f6r ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131t\u0131n\u0131 destekleyerek t\u00fcm\u00f6rde ba\u011f\u0131\u015f\u0131kl\u0131k g\u00f6zetimini art\u0131rd\u0131\u011f\u0131na i\u015faret ediyor ve b\u00f6ylece tedaviye yan\u0131t \u015fans\u0131n\u0131 y\u00fckseltebilir.<\/p>\n
Daha derin analizler, CHRDL1 y\u00fcksek olan t\u00fcm\u00f6rlerin daha iyi ba\u011f\u0131\u015f\u0131kl\u0131k profillerine sahip oldu\u011funu ve t\u00fcm\u00f6r k\u00f6k h\u00fccre \u00f6zelliklerinin ise azald\u0131\u011f\u0131n\u0131 g\u00f6sterdi. T\u00fcm\u00f6r k\u00f6k h\u00fccreli\u011fi, tedavi direnci ve metastaz ile ba\u011flant\u0131l\u0131yken, CHRDL1\u2019in bu \u00f6zellikle ters orant\u0131l\u0131 olmas\u0131, proteinin t\u00fcm\u00f6r heterojenli\u011fi ve agresifli\u011fini s\u0131n\u0131rland\u0131rd\u0131\u011f\u0131n\u0131 ve ba\u011f\u0131\u015f\u0131kl\u0131k kontrol\u00fcn\u00fc kolayla\u015ft\u0131rd\u0131\u011f\u0131n\u0131 kan\u0131tl\u0131yor.<\/p>\n
Bioinformatik analizlerin \u00f6tesinde, ara\u015ft\u0131rmac\u0131lar CHRDL1\u2019i A549 ve H1299 akci\u011fer adenokarsinom h\u00fccre hatlar\u0131nda yapay olarak \u00e7o\u011faltarak do\u011frulama \u00e7al\u0131\u015fmalar\u0131 yapt\u0131. CHRDL1\u2019nin fazlal\u0131\u011f\u0131, h\u00fccre proliferasyonu, g\u00f6\u00e7 ve invazyon kapasitesinde anlaml\u0131 azalmalarla sonu\u00e7land\u0131. CCK-8 testleri ve yara iyile\u015fme ile invazyon deneyleri, CHRDL1\u2019in kanser h\u00fccrelerinin agresif davran\u0131\u015f\u0131n\u0131 do\u011frudan bask\u0131lad\u0131\u011f\u0131n\u0131 fizyolojik olarak destekledi.<\/p>\n
In vivo olarak ise ba\u011f\u0131\u015f\u0131kl\u0131k sistemi bask\u0131lanm\u0131\u015f \u00e7\u0131plak farelerde ger\u00e7ekle\u015ftirilen subkutan t\u00fcm\u00f6r olu\u015fum testlerinde CHRDL1 a\u015f\u0131r\u0131 eksprese eden h\u00fccrelerden geli\u015fen t\u00fcm\u00f6rler daha yava\u015f b\u00fcy\u00fcyerek biyobelirtecin t\u00fcm\u00f6r olu\u015fumunu engelleme kapasitesi teyit edildi. Bu deneysel sonu\u00e7lar, CHRDL1\u2019in terap\u00f6tik m\u00fcdahalelerle art\u0131r\u0131lmas\u0131 halinde tedavi avantajlar\u0131 sa\u011flayabilece\u011finin somut kan\u0131t\u0131 oldu.<\/p>\n
Pan-kanser yakla\u015f\u0131m\u0131, CHRDL1\u2019in sadece akci\u011fer kanseriyle s\u0131n\u0131rl\u0131 olmayan, \u00e7ok y\u00f6nl\u00fc t\u00fcm\u00f6r biyolojisi \u00fczerindeki rol\u00fcn\u00fc ortaya koydu. Hem t\u00fcm\u00f6r h\u00fccre i\u00e7i mekanizmalar hem de ba\u011f\u0131\u015f\u0131kl\u0131k mikro\u00e7evresi \u00fczerindeki d\u00fczenleyici etkileri, proteini immunoterapi kombinasyonlar\u0131nda kullan\u0131labilecek de\u011ferli bir hedef haline getirdi.<\/p>\n
Bununla beraber, \u00e7al\u0131\u015fmada CHRDL1\u2019in BMP sinyal yoluyla ve t\u00fcm\u00f6r mikro\u00e7evresiyle nas\u0131l etkile\u015fti\u011fine dair daha derin mekanik a\u00e7\u0131klamalara ihtiya\u00e7 oldu\u011fu vurguland\u0131. BMP yolaklar\u0131n\u0131n t\u00fcm\u00f6r geli\u015fimindeki karma\u015f\u0131k, ba\u011flama \u00f6zg\u00fc rol\u00fc g\u00f6z \u00f6n\u00fcnde bulunduruldu\u011funda, CHRDL1\u2019in rol\u00fc yeni bir d\u00fczenleyici eksen olarak ayr\u0131ca incelenmeye a\u00e7\u0131k.<\/p>\n
Ayr\u0131ca, CHRDL1\u2019in ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccre infiltrasyonu ve t\u00fcm\u00f6r\u00fcn k\u00f6k h\u00fccre \u00f6zellikleriyle olan ili\u015fkisi, imm\u00fcn ka\u00e7\u0131\u015f\u0131 tersine \u00e7evirecek ve t\u00fcm\u00f6r heterojenitesini azaltacak yenilik\u00e7i tedavi stratejilerinin geli\u015ftirilmesini te\u015fvik ediyor. Genetik olarak CHRDL1\u2019in artt\u0131r\u0131lmas\u0131 veya rekombinant CHRDL1 proteinlerinin tedavilerde kullan\u0131lmas\u0131, ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131t\u0131n\u0131 g\u00fc\u00e7lendirmek i\u00e7in yeni ufuklar a\u00e7abilir.<\/p>\n
\u00c7al\u0131\u015fmada cevaplanmam\u0131\u015f kimi sorular da bulunuyor. CHRDL1\u2019in t\u00fcm\u00f6rlerde neden azald\u0131\u011f\u0131n\u0131 belirleyen yukar\u0131 ak\u0131\u015f reg\u00fclat\u00f6rlerinin ve bu proteinin bask\u0131lay\u0131c\u0131 etkisini ortaya \u00e7\u0131karan a\u015fa\u011f\u0131 ak\u0131\u015f hedeflerinin tan\u0131mlanmas\u0131 gerekiyor. Ayr\u0131ca, farkl\u0131 kanser t\u00fcrleri ve hasta gruplar\u0131 \u00fczerinde yap\u0131lacak ilave ara\u015ft\u0131rmalar, CHRDL1\u2019in prognostik de\u011ferinin genellenebilirli\u011fini ve \u00f6zg\u00fcll\u00fc\u011f\u00fcn\u00fc netle\u015ftirebilir.<\/p>\n
T\u00fcm\u00f6rlerin dinamik ve heterojen yap\u0131s\u0131 d\u00fc\u015f\u00fcn\u00fcld\u00fc\u011f\u00fcnde, CHRDL1 d\u00fczeyi ile di\u011fer molek\u00fcler ve klinik fakt\u00f6rlerin birlikte de\u011ferlendirilerek ki\u015fiye \u00f6zg\u00fc tedavi stratejilerinin geli\u015ftirilmesi \u00f6nemli. \u00d6zellikle d\u00fc\u015f\u00fck CHRDL1 ekspresyonuna sahip hastalara, BMP yolak mod\u00fclat\u00f6rleri ve ba\u011f\u0131\u015f\u0131kl\u0131k tedavilerinin kombinasyonunun uygulanmas\u0131 \u00f6nerilebilir.<\/p>\n
Bu ara\u015ft\u0131rma, hesaplamal\u0131 onkoloji, molek\u00fcler biyoloji ve imm\u00fcnoloji alanlar\u0131n\u0131n birbirine giderek daha fazla entegre oldu\u011fu yeni d\u00f6nemin \u00f6rneklerinden biri. Geni\u015f \u00e7apl\u0131 multi-omik veri analizleri ile g\u00fc\u00e7l\u00fc deneysel validasyonlar\u0131 birle\u015ftiren \u00e7al\u0131\u015fma, gelecekte biyobelirte\u00e7 ke\u015ffi ve fonksiyonel karakterizasyon \u00e7al\u0131\u015fmalar\u0131na \u00f6nc\u00fcl\u00fck edecek bir yakla\u015f\u0131m sundu.<\/p>\n
\u00d6zetle, Ou, Gao, Hu ve ekip arkada\u015flar\u0131n\u0131n \u00f6nc\u00fcl\u00fc\u011f\u00fcnde yap\u0131lan kapsaml\u0131 pan-kanser analizi, CHRDL1\u2019in akci\u011fer adenokarsinomundaki t\u00fcm\u00f6r bask\u0131lay\u0131c\u0131 ve ba\u011f\u0131\u015f\u0131kl\u0131k d\u00fczenleyici y\u00f6nlerini ortaya koydu. Onkoloji camias\u0131nda t\u00fcm\u00f6r sinyalle\u015fme ve ba\u011f\u0131\u015f\u0131kl\u0131k etkile\u015fimi aras\u0131ndaki karma\u015f\u0131k ba\u011flar\u0131n \u00e7\u00f6z\u00fclmesinde CHRDL1, yeni tan\u0131sal ve terap\u00f6tik kap\u0131lar a\u00e7acak bir umut \u0131\u015f\u0131\u011f\u0131 olarak yerini ald\u0131.<\/p>\n
Artan klinik kan\u0131tlar CHRDL1\u2019in hasta y\u00f6netiminde yol g\u00f6sterici olabilece\u011fini g\u00f6sterirken, gelecekte uygulanacak tedavilerde bu hedefin desteklenmesi kanserlerle m\u00fccadelede \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 geli\u015fmelerin yolunu a\u00e7abilir. Bu anlaml\u0131 \u00e7al\u0131\u015fma; ki\u015fiselle\u015ftirilmi\u015f t\u0131p ve imm\u00fcno-onkoloji \u00e7a\u011f\u0131nda CHRDL1\u2019in g\u00fcc\u00fcnden yararlanmak i\u00e7in at\u0131lan kritik bir ad\u0131m olarak tarihteki yerini ald\u0131.<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Makale Ba\u015fl\u0131\u011f\u0131<\/strong>: Haberin Yay\u0131n Tarihi<\/strong>: Web References<\/strong>: Doi Referans<\/strong>: Resim Credits<\/strong>: Anahtar Kelimeler<\/strong>: Son zamanlarda BMC Cancer\u2019da yay\u0131mlanan \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 bir \u00e7al\u0131\u015fma, Chordin-like 1 (CHRDL1) proteininin bir\u00e7ok kanser t\u00fcr\u00fcndeki kritik rol\u00fcn\u00fc ortaya koydu. \u00d6zellikle akci\u011fer adenokarsinomunda (LUAD) \u00f6nemli etkileri g\u00f6sterilen CHRDL1, kemik morfogenetik proteinlerin (BMP) antagonisti olarak; t\u00fcm\u00f6r davran\u0131\u015f\u0131, ba\u011f\u0131\u015f\u0131kl\u0131k infiltrasyonu ve hastalar\u0131n prognozu \u00fczerinde \u00e7ok y\u00f6nl\u00fc etkiler g\u00f6steriyor. Pan-kanser analiziyle desteklenen ve deneysel do\u011frulamalarla g\u00fc\u00e7lendirilen bu \u00e7al\u0131\u015fma,…<\/p>\n","protected":false},"author":1,"featured_media":3942,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[3384,3381,3383,3385,3382],"tmauthors":[],"class_list":{"0":"post-3941","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-akciger-adenokarsinomu-prognostik-biyobelirtecleri","9":"tag-chrdl1-akciger-kanseri-rolu","10":"tag-chrdl1-bagisiklik-mikrocevresi-etkisi","11":"tag-kanser-tedavisinde-chrdl1-hedeflemesi","12":"tag-pan-kanser-chrdl1-ekspresyon-analizi"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/Pan-Kanser-CHRDL1-Incelemesi-Akciger-Kanseri-Rolu-1745675994.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3941","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=3941"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3941\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/3942"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=3941"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=3941"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=3941"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=3941"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nChordin-like 1 (CHRDL1) ifadesi ve fonksiyonel ile prognostik rolleri, pan-kanser analizi ve akci\u011fer adenokarsinomu deneysel do\u011frulamalar\u0131.<\/p>\n
\nComprehensive pan-cancer analysis of CHRDL1 and experimental validation of its role in lung adenocarcinoma<\/p>\n
\n2025<\/p>\n
\nhttps:\/\/doi.org\/10.1186\/s12885-025-14174-0<\/p>\n
\nhttps:\/\/doi.org\/10.1186\/s12885-025-14174-0<\/p>\n
\nScienmag.com<\/p>\n
\nBMP sinyal yolu, Chordin-like 1, t\u00fcm\u00f6r bask\u0131lay\u0131c\u0131, prognoz belirteci, akci\u011fer adenokarsinomu, ba\u011f\u0131\u015f\u0131kl\u0131k infiltrasyonu, t\u00fcm\u00f6r k\u00f6k h\u00fccreli\u011fi, pan-kanser analiz, imm\u00fcnoterapi hedefi, molek\u00fcler onkoloji<\/p>\n","protected":false},"excerpt":{"rendered":"